new version V2017

anti inflammatory drugs

Canakinumab      

TrialStudied treatmentControl treatmentpatientsROBResultNCT

percutaneous coronary intervention

pexelizumab
APEX-AMI, 2007pexelizumabplacebo Low risk of bias NegativeNCT00091637